Triple -Negative Breast Cancer

Explore clinical trials studying Triple -Negative Breast Cancer. Study availability and eligibility vary by location and protocol.

9 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Triple -Negative Breast Cancer trial results

Recruiting

THE-0504 in Patients With Solid Tumors

NCT07646106

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome, Lazio, Italy

View Trial Details

Recruiting

Phase III Trial of Camrelizumab+Apatinib+Eribulin vs. Physician's Choice Chemotherapy in Advanced Triple-Negative Breast Cancer

NCT06889688

Conditions: Breast Cancer Stage IV, Breast Diseases, Breast Neoplasms, +6 more
Locations: Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China

The Affiliated Hospital of Guizhou Medical University Guiyang, Guizhou, China

Wuhan Union Hospital of China Wuhan, Hubei, China

Yichang Central People's Hospital Yichang, Hubei, China

View Trial Details

Recruiting

A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha

NCT06547840

Conditions: Advanced Endometrial Cancer, Advanced Ovarian Cancer, Breast Diseases, +20 more
Locations: Bristol Haematology and Oncology Centre Bristol, United Kingdom

Edinburgh Cancer Research Centre Edinburgh, United Kingdom

Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom

Cambridge University - Addenbrooke's Hospital London, United Kingdom

View Trial Details

Recruiting

Efficacy and Safety of Extended-Dose Interval Immunotherapy Versus Standard-Dose Interval Immunotherapy for Advanced Triple-Negative Breast Cancer

NCT07401537

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations: Breast Tumor Center, Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Pembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After Neoadjuvant Pembrolizumab Plus Chemotherapy

NCT07486687

Conditions: Breast Cancer Stage II, Breast Cancer Stage III, Breast Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer

NCT07419880

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan in Neoadjuvant Treatment of Early-Stage TNBC

NCT07007780

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Not specified

View Trial Details

Completed

Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer

NCT07143097

Conditions: Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations: Faculty of Medicine Banī Suwayf, Egypt

View Trial Details

Completed

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

NCT03599453

Conditions: Anatomic Stage IV Breast Cancer AJCC, Breast Diseases, Breast Neoplasms, +9 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Triple -Negative Breast Cancer

Triple -Negative Breast Cancer trial results

Related conditions